INTELLIGENT BIO SOLUTIONS INC. 8-K
Research Summary
AI-generated summary
Intelligent Bio Solutions Reports Results for Quarter Ended Dec 31, 2025
What Happened
- Intelligent Bio Solutions, Inc. announced financial results for the fiscal quarter ended December 31, 2025. The company issued a press release dated February 12, 2026, and furnished that release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02).
- The Form 8-K notes the press release and related information are furnished (not filed) and are not incorporated by reference into other company filings, and therefore are not subject to certain liability provisions of the securities laws.
Key Details
- Date of announcement: February 12, 2026.
- Reporting period: fiscal quarter ended December 31, 2025.
- Exhibit furnished: Press release is included as Exhibit 99.1 to the Form 8-K.
- The filing includes an Inline XBRL cover page interactive data file (Exhibit 104); the press release information is furnished and expressly not incorporated by reference or deemed “filed” under certain sections of the securities laws.
Why It Matters
- This 8-K signals the company has released its latest quarterly results; investors should read the February 12, 2026 press release (Exhibit 99.1) for revenue, earnings, cash position, and any commentary or guidance the company provided.
- The legal note that the release is “furnished” (not “filed”) means the press release is disclosed to the market but is not being incorporated into other SEC filings for liability purposes.